« Back
Home /
Lecanemab

Lecanemab

Item no.	HY-P99689-10mg
Manufacturer	MedChem Express
CASRN	1260393-98-3
Amount	10 mg
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Purity	95.0%
Dry ice	Yes
Citations	[1].Söderberg L, et al. Lecanemab, Aducanumab, and Gantenerumab - Binding Profiles to Different Forms of Amyloid-Beta Might Explain Efficacy and Side Effects in Clinical Trials for Alzheimer's Disease. Neurotherapeutics. 2022 Oct 17. [2].McDade E, et al. Lecanemab in patients with early Alzheimer's disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept study. Alzheimers Res Ther. 2022 Dec 21;14(1):191.
Smiles	[Lecanemab]
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	BAN-2401
Available
Product Description	Lecanemab (BAN-2401) is a humanized IgG1 anti-soluble aggregated amyloid beta (Aβ) monoclonal antibody. Lecanemab shows activity across oligomers, protofibrils and insoluble fibrils. Lecanemab can be used for the research of Alzheimer's Disease.
StorageTemperature	Please store the product under the recommended conditions in the Certificate of Analysis.
Shipping	Shipping with dry ice
Applications	Neuroscience-Neurodegeneration
Clinical_Information	Phase 3
Research_Area	Neurological Disease
Target	Amyloid-β
Pathway	Neuronal Signaling
MCE Product type	Inhibitory Antibodies

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 10 mg

not available